These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 7514814

  • 1. [Chemotherapy in lung carcinoma].
    Egger T, Cerny T.
    Ther Umsch; 1994 Apr; 51(4):267-71. PubMed ID: 7514814
    [Abstract] [Full Text] [Related]

  • 2. Second-line for small cell lung cancer: how-to-do-it?
    Postmus PE.
    Lung Cancer; 2005 May; 48(2):263-5. PubMed ID: 15829327
    [No Abstract] [Full Text] [Related]

  • 3. [Chemotherapy of bronchial carcinoma].
    Drings P.
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():340-3. PubMed ID: 2459687
    [No Abstract] [Full Text] [Related]

  • 4. [Recent progress in chemotherapy for advanced lung cancer].
    Negoro S, Fukuoka M.
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):451-60. PubMed ID: 7887637
    [Abstract] [Full Text] [Related]

  • 5. [Drug therapy in bronchial carcinoma].
    Manegold C, Drings P.
    Schweiz Med Wochenschr; 1995 Jul 22; 125(29):1396-405. PubMed ID: 7545824
    [Abstract] [Full Text] [Related]

  • 6. Recent advances in chemotherapy for lung cancer.
    Lilenbaum RC.
    Curr Opin Pulm Med; 1996 Jul 22; 2(4):285-9. PubMed ID: 9363153
    [Abstract] [Full Text] [Related]

  • 7. [Second-line chemotherapy in non-small-cell lung cancer].
    Schütte W.
    Rev Pneumol Clin; 2004 Nov 22; 60(5 Pt 3):4S13-4S16. PubMed ID: 15687987
    [No Abstract] [Full Text] [Related]

  • 8. [Possibilities of chemotherapy in patients with bronchial cancer].
    Hossfeld DK, Zschaber R, Gatzemeier U, Koschel G, Kaukel E, Heilmann HP.
    Rontgenblatter; 1988 Mar 22; 41(3):113-6. PubMed ID: 2838891
    [Abstract] [Full Text] [Related]

  • 9. Treatment of brain metastases from lung cancer: chemotherapy.
    Schuette W.
    Lung Cancer; 2004 Aug 22; 45 Suppl 2():S253-7. PubMed ID: 15552807
    [Abstract] [Full Text] [Related]

  • 10. [Current progress in chemotherapy for bronchial cancer].
    Sculier JP.
    Rev Med Brux; 1995 Aug 22; 16(2):55-63. PubMed ID: 7784737
    [Abstract] [Full Text] [Related]

  • 11. [Chemotherapy in cancer of the lung].
    Gütz S.
    MMW Fortschr Med; 2006 Jun 01; 148(22):33-4. PubMed ID: 16821578
    [Abstract] [Full Text] [Related]

  • 12. The role of chemotherapy in the treatment of lung cancer.
    Pate RW.
    Nurs Clin North Am; 1992 Sep 01; 27(3):653-63. PubMed ID: 1324481
    [Abstract] [Full Text] [Related]

  • 13. New treatment agents for advanced small cell and non-small cell lung cancer.
    Bunn PA, Kelly K.
    Semin Oncol; 1995 Jun 01; 22(3 Suppl 6):53-63. PubMed ID: 7597434
    [Abstract] [Full Text] [Related]

  • 14. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD, Greco FA.
    Semin Oncol; 1995 Dec 01; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [Abstract] [Full Text] [Related]

  • 15. First-line chemotherapy in metastatic small-cell lung cancer (SCLC).
    Wolf M, Tebbe S, Fink T.
    Lung Cancer; 2004 Aug 01; 45 Suppl 2():S223-34. PubMed ID: 15552803
    [Abstract] [Full Text] [Related]

  • 16. [Recent development in the treatment of lung cancer: from the point of view of the medical oncologist].
    Joss R.
    Schweiz Med Wochenschr; 2000 May 13; 130(19):684-90. PubMed ID: 10846762
    [Abstract] [Full Text] [Related]

  • 17. Can weight loss at presentation predict patient outcome in lung cancer?
    Temel J.
    Nat Clin Pract Oncol; 2004 Dec 13; 1(2):68-9. PubMed ID: 16264819
    [No Abstract] [Full Text] [Related]

  • 18. [Effects, possibilities and limits. Cytostatic therapy of small cell and non-small cell lung cancer].
    Bergman B.
    Lakartidningen; 1997 Apr 30; 94(18):1702, 1707-10. PubMed ID: 9182178
    [No Abstract] [Full Text] [Related]

  • 19. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Aamdal S, Norwegian Lung Cancer Study Group.
    Lung Cancer; 2005 May 30; 48(2):251-61. PubMed ID: 15829326
    [Abstract] [Full Text] [Related]

  • 20. "Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial".
    Holoye PY.
    Cancer Treat Rep; 1987 Apr 30; 71(4):431-2. PubMed ID: 3030548
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.